Clinical Trials Browser

Phase 2/3 × Neoplasm Metastasis × Head & Neck × Clear all

NCT04534205 2026-05-22

AHEAD-MERIT

Phase 2/3 Recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT06719479 2024-12-05

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

Phase 2/3 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT04890522 2021-05-18

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

Phase 2/3 Not yet recruiting

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT00401323 2011-01-20

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Phase 2/3 Completed

Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local